Group 1 - The company China General Nuclear Power Technology (中广核技) expects a net profit loss of 90 million to 120 million yuan in the first half of 2025, compared to a loss of 86.5778 million yuan in the same period last year [1]

Core Viewpoint - The Mianyang Nuclear Medical Health Industrial Park has signed 28 projects with a total investment of 22.3 billion yuan, indicating a strong interest in the nuclear medical sector in Mianyang [4][12]. Investment and Development - Recent capital movements in the nuclear medical sector include the completion of A+ round financing by Guotong New Drug, and the listing application by Xiantong Pharmaceutical on the Hong Kong Stock Exchange [2][3]. - The Mianyang Nuclear Medical Health Industrial Park has attracted significant investment, with 28 projects signed and a total investment amounting to 223 billion yuan [4][12]. Technological Advancements - The park features advanced radiation therapy technologies, including the X-Flash and e-Flash devices, which utilize Flash radiation therapy to significantly reduce treatment time while maintaining efficacy [6][8]. - The first domestic proton therapy device is set to be produced in Mianyang, with a production base for proton equipment expected to be completed by June 2024 [9][11]. Supply Chain and Resource Availability - Mianyang has become a major supplier of medical isotopes, with a focus on the production of iodine-131 and lutetium-177, which are critical for nuclear medicine [11][24]. - The proximity of Xiantong Pharmaceutical to the isotope production base enhances supply convenience, making Mianyang an attractive location for nuclear medicine companies [11][12]. Collaborative Efforts and Government Support - The rapid development of the nuclear medical industrial park is supported by collaborations between enterprises and research institutions, as well as government initiatives [12][15]. - The local government has committed over 13 billion yuan in special bonds and guiding funds to support infrastructure and research projects in the nuclear medical sector [27]. Talent and Research Development - Mianyang has a strong talent pool, with significant investments in education and research institutions focused on nuclear science and technology [23][24]. - The establishment of key laboratories and research platforms in Mianyang aims to address critical challenges in nuclear technology applications [26].

Core Insights - The report highlights the impact of the recent US-Vietnam trade agreement on China's textile exports, with US tariffs on Vietnam reduced from 46% to 20%, potentially leading to a shift of orders from US buyers to Vietnam [8] - The outdoor industry is expected to continue thriving, supported by increasing participation in events and a growing market for outdoor products, with a target industry scale exceeding 3 trillion yuan by 2025 [9] - The real estate market is anticipated to stabilize, with potential policy support from the government, which may positively influence the home furnishing sector [10] Economic News - The National Development and Reform Commission has allocated an additional 10 billion yuan for employment projects, expected to create jobs for 310,000 individuals [2] - The People's Bank of China is exploring new measures to open the bond market to foreign investors, aiming to enhance the liquidity of RMB bonds [3] - The Hong Kong Monetary Authority plans to expand offshore RMB repurchase operations, enhancing market liquidity and supporting the development of the Hong Kong bond market [4] Company News - Shentong Express has partnered with Cainiao to advance the application of unmanned vehicles in last-mile delivery, aiming to enhance its smart delivery network [6] - Huawei has announced a new patent for an auxiliary driving method, which aims to improve drivers' perception of surrounding obstacles [6] - JD.com has launched a "Double Hundred Plan" to invest over 10 billion yuan to support quality merchants, enhancing their online sales capabilities [6] Market Review - The textile and apparel industry saw a 1.36% increase, while the light industry rose by 0.58%, indicating a positive trend in these sectors [11]

东 兴 晨 报 东兴晨报 P1 3.商务部等 9 部门：联合印发《2025 年家政兴农行动工作方案》。该方案从四 个方面提出 14 项具体任务，旨在扩大家政服务供给，促进家政服务消费，助 力乡村振兴。主要措施包括：支持农村劳动力在家政领域就业，开展生活服 务招聘季活动；提升就业能力，推进家政服务员技能升级和职业教育发展； 完善就业保障，加强住房保障和基本公共服务；优化创业就业服务，支持重 点群体就业创业。下一步，商务部将联合相关部门推动政策落实，充分发挥 家政服务业在惠民生、稳就业、促消费方面的重要作用。（资料来源：同花顺） 4.中国人民银行：开展 1065 亿元 7 天期逆回购操作。人民银行 7 日公告称， 以固定利率、数量招标方式开展了 1065 亿元逆回购操作，中标利率为 1.4%。 今日公开市场有 3315 亿元逆回购到期，净回笼 2250 亿元。（资料来源：同花 顺） 5.三大交易所：正式实施程序化交易监管新规。7 月 7 日起，沪深北三大交易 所《程序化交易管理实施细则》正式实施，重点强化高频交易监管。新规明 确了四类异常交易行为认定标准，包括瞬时申报速率异常、频繁瞬时撤单等， 并将单账户每秒申报 ...

致:中广核核技术发展股份有限公司 北京市君合(深圳)律师事务所(以下简称"本所")受中广核核技术发展股份 有限公司(以下简称"贵公司"或"公司")的委托,就贵公司 2024年年度股东会 (以下简称"本次股东会")召开的有关事宜,根据《中华人民共和国公司法》(以 下简称"《公司法》")、《中华人民共和国证券法》《上市公司股东会规则》(以下简 称"《股东会规则》")等中国(包括香港特别行政区、澳门特别行政区和台湾省, 为出具本法律意见书之目的,特指中国大陆地区)现行法律、法规和规范性文件(以 下简称"中国法律、法规")以及现行《中广核核技术发展股份有限公司公司章程》 (以下简称"《公司章程》"）的有关规定,出具本法律意见书。 本法律意见书仅就本次股东会的召集和召开程序、出席本次股东会人员的资格、 召集人资格、会议表决程序是否符合中国法律、法规及《公司章程》的规定以及表 决结果是否合法有效发表意见,并不对本次股东会所审议的议案内容以及该等议案 所表述的相关事实或数据的真实性、准确性或合法性发表意见。 在本法律意见书中,本所仅依据本法律意见书出具日及以前发生的事实及本所 对该事实的了解,并仅就本次股东会所涉及的相关中 ...

证券代码：000881 证券简称：中广核技 公告编号：2025-031 中广核核技术发展股份有限公司 2024 年年度股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 特别提示： 1.本次股东会未出现否决议案的情形。 2.本次股东会不涉及变更以往股东会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开的日期、时间： （1）现场会议召开日期、时间：2025 年 6 月 30 日（星期一）下午 2:30； （2）网络投票日期、时间：通过深圳证券交易所交易系统进行网络投票的具 体时间为：2025 年 6 月 30 日上午 9:15 至 9:25、9:30 至 11:30、下午 1:00 至 3:00； 通过深圳证券交易所互联网投票系统投票的具体时间为 2025 年6 月 30 日上午 9:15 至下午 3:00 期间的任意时间。 2.会议召开方式：本次股东会采取现场投票与网络投票相结合的方式。 3.现场会议召开地点：深圳市福田区深南大道 2002 号中广核大厦北楼 19 层 881 会议室。 4.召集人：公司董事会。 5.主持人： ...

Core Insights - The domestic high-performance Silicon Photomultiplier (SiPM) has achieved significant breakthroughs in localization, marking a successful end to foreign monopolization in this sector [2] - SiPMs are crucial optical-electronic conversion devices with applications in nuclear medical imaging, nuclear measurement and control equipment, high-energy physics research, and biological sciences, showcasing immense potential [2] - The establishment of Zhongjing Optoelectronics by China General Nuclear Power Corporation (CGN) and Beijing Normal University aims to promote the transformation of technological achievements with proprietary technologies [2][3] Company Developments - Zhongjing Optoelectronics has successfully established a packaging production line with a device yield exceeding 90%, filling the gap in the domestic high-performance SiPM market [2] - The company invested in a high-standard cleanroom facility and designed a high-level packaging production line that integrates standardized production and quality control [3] - The production line has passed EU RoHS certification and is on track to achieve ISO certification, laying a solid foundation for large-scale application and market expansion [3] Market Strategy - The company is focused on optimizing SiPM product performance and is actively pursuing market expansion in relevant fields [3] - The goal is to build core competitiveness and self-sustaining development capabilities, contributing to the localization and autonomy of high-end equipment in China [3]

中广核核技术发展股份有限公司 关于部分限售股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 重要内容提示： 1.本次解除限售的流通股涉及股东 25 名，解除限售股份数量为 43,393,059 股，占公司总股本的 4.5898%； 2.本次解除限售的流通股上市日期为 2025 年 7 月 1 日。 一、本次解除限售股份的基本情况 经中国证券监督管理委员会（以下简称"中国证监会"）《关于核准中国大 连国际合作（集团）股份有限公司向中广核核技术应用有限公司等发行股份购买 资产并募集配套资金的批复》（证监许可[2016]2412 号）核准，中广核核技术 发展股份有限公司（原"中国大连国际合作（集团）股份有限公司"，以下简称 "中广核技"、"公司"、"上市公司"或"大连国际"）向中广核核技术应用 有限公司（以下简称"中广核核技术"）等四十六名交易对方发行 478,993,166 股人民币普通股（A 股）购买资产，同时向七家配套融资方非公开发行不超过 267,686,421 股人民币普通股（A 股）募集本次发行股份购买资产的配套资金（以 下简称 ...

中德证券有限责任公司关于中广核核技术发展股份有限公司 发行股份购买资产并募集配套资金暨关联交易之 部分限售股解禁的核查意见 中德证券有限责任公司（以下简称"中德证券"、"独立财务顾问"）作为中 广核核技术发展股份有限公司（以下简称"中广核技"、"大连国际"或"公司"） 发行股份购买资产并募集配套资金暨关联交易的独立财务顾问，根据《公司法》、 《证券法》、《上市公司重大资产重组管理办法》、《深圳证券交易所股票上市规则》 等有关规定的相关要求，对中广核技发行股份购买资产并募集配套资金暨关联交 易的部分限售股份解禁事项进行了核查，具体情况如下： 一、本次解除限售股份的基本情况 经中国证券监督管理委员会（以下简称"中国证监会"）《关于核准中国大连 国际合作（集团）股份有限公司向中广核核技术应用有限公司等发行股份购买资 产并募集配套资金的批复》（证监许可[2016]2412 号）核准，中广核核技术发展 股份有限公司（原"中国大连国际合作（集团）股份有限公司"，以下简称"中 广核技"、"公司"、"上市公司"或"大连国际"）向中广核核技术应用有限公司 （以下简称"中广核核技术"）等四十六名交易对方发行 478,993,16 ...

Core Insights - Significant breakthrough in the domestic production of high-performance Silicon Photomultiplier (SiPM) in China, marking the end of foreign monopoly in this sector [1] - The successful establishment of the SiPM packaging production line by China General Nuclear Power Corporation (CGN) and its subsidiary, CGN Beijing Institute of Optoelectronics Technology, achieving over 90% yield rate [1] Group 1 - SiPM is a core optoelectronic conversion device with advantages such as high sensitivity, low noise, and low power consumption, widely used in nuclear medical imaging, nuclear measurement and control equipment, high-energy physics research, and biological sciences [1] - The domestic SiPM market has been dominated by foreign companies until now, highlighting the importance of this development for national security and technological independence [1] Group 2 - The company invested in building a high-standard cleanroom with a cleanliness level of up to 100, and designed a high-level packaging production line that integrates standardized production and quality control [2] - Future plans include optimizing SiPM product performance based on market demand and customer feedback, while focusing on market expansion in relevant fields to enhance core competitiveness and ensure the resilience and safety of the industrial chain [2]